From severity-guided to C-reactive protein–guided corticosteroid treatment
Authors:
- 21 February 2026
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 212 (5) , 1073-1074
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2025
- Effect of hydrocortisone on mortality in patients with severe community-acquired pneumoniaIntensive Care Medicine, 2025
- Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trialsThe Lancet Respiratory Medicine, 2025
- ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategiesIntensive Care Medicine, 2023
- Hydrocortisone in Severe Community-Acquired PneumoniaNew England Journal of Medicine, 2023
- Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumoniaIntensive Care Medicine, 2022